Lutetium-177-PSMA-617

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 21:00, 24 March 2022 by PeterYang (talk | contribs) (PeterYang moved page Lutetium-177-PSMA-617 to Lutetium Lu 177 vipivotide tetraxetan (Pluvicto): FDA approval)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Redirect page
Jump to navigation Jump to search

Redirect to:

Retrieved from "https://hemonc.org/w/index.php?title=Lutetium-177-PSMA-617&oldid=55339"